US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

32.22

-0.2200-0.68%

Post-market: 32.220.00000.00%16:32 EST

Volume:572.66K

Turnover:18.33M

Market Cap:1.84B

PE:47.06

High:32.90

Open:32.49

Low:30.91

Close:32.44

52wk High:38.69

52wk Low:5.35

Shares:57.12M

Float Shares:38.09M

Volume Ratio:0.86

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.6847

EPS(LYR):-1.6475

ROE:15.02%

ROA:5.20%

PB:5.97

PE(LYR):-19.56

Loading ...

Overview Company News Filings

High Growth Tech Stocks In The US February 2026

Simply Wall St.

Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment

MT Newswires Live

BRIEF-Stoke Therapeutics Announces First Patient Dosed In Phase 1 Study Of Stk-002

Stoke Therapeutics Doses First Patient in Phase 1 Trial of STK-002 for Autosomal Dominant Optic Atrophy

Stoke Therapeutics Inc: Dose Escalation of First Four Cohorts Will Continue Through 2026 and Early 2027, Pending Safety and Tolerability Assessments

THOMSON REUTERS

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of Stk-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (Adoa)

THOMSON REUTERS

Stoke Therapeutics präsentiert auf dem Guggenheim Emerging Outlook: Biotech Summit

Will Stoke’s New Waltham Headquarters for Zorevunersen Commercialization Shift Stoke Therapeutics' (STOK) Narrative?

Simply Wall St.

Stoke Therapeutics Signs Lease for New 98,500-Square-Foot Headquarters in Waltham

How Accelerated EMPEROR Enrollment and Expedited FDA Talks At Stoke Therapeutics (STOK) Have Changed Its Investment Story

Simply Wall St.

Stoke Therapeutics (STOK) Valuation Check As Phase 3 Dravet Study Advances And FDA Discussions Progress

Simply Wall St.

Stoke Therapeutics Grants Stock Options to New Employees Under Inducement Plan

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Stoke Therapeutics Down Over 16%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

Stoke Therapeutics to Present at J.P. Morgan Healthcare Conference

Stoke Therapeutics updates timeline for Phase 3 EMPEROR study

Stoke Therapeutics Showcases Pipeline Advancements for Dravet Syndrome and Rare Genetic Diseases

BRIEF-Stoke Therapeutics Expects To Complete Enrollment Of 150 Patients In Q2 2026, With A Phase 3 Data Readout In Mid-2027 for Zorevunersen

Stoke Therapeutics Accelerates Phase 3 EMPEROR Study Enrollment for Dravet Syndrome Drug Zorevunersen

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout From the Emperor Study of Zorevunersen for the Treatment of Dravet Syndrome

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/STOK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"STOK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STOK\",,,,,undefined,":{"symbol":"STOK","market":"US","secType":"STK","nameCN":"Stoke Therapeutics, Inc.","latestPrice":32.22,"timestamp":1770843600000,"preClose":32.44,"halted":0,"volume":572660,"hourTrading":{"tag":"盘后","latestPrice":32.22,"preClose":32.22,"latestTime":"16:32 EST","volume":3747,"amount":120728.34,"timestamp":1770845545709,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006781750924784183,"floatShares":38091405,"shares":57117150,"eps":0.684705,"marketStatus":"Not Yet Opened","change":-0.22,"latestTime":"02-11 16:00:00 EST","open":32.49,"high":32.9,"low":30.91,"amount":18325669.7536,"amplitude":0.061344,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.684705,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770886800000},"marketStatusCode":0,"adr":0,"listingDate":1560916800000,"exchange":"NASDAQ","adjPreClose":32.44,"preHourTrading":{"tag":"盘前","latestPrice":32.41,"preClose":32.44,"latestTime":"09:29 EST","volume":1246,"amount":40450.439302,"timestamp":1770820199909,"change":-0.03,"changeRate":-0.000925,"amplitude":0.021578},"postHourTrading":{"tag":"盘后","latestPrice":32.22,"preClose":32.22,"latestTime":"16:32 EST","volume":3747,"amount":120728.34,"timestamp":1770845545709,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.856396,"impliedVol":0.8054,"impliedVolPercentile":0.3944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STOK\",,,,,undefined,":{"symbol":"STOK","floatShares":38091405,"roa":"5.20%","roe":"15.02%","lyrEps":-1.647525,"volumeRatio":0.856396,"shares":57117150,"dividePrice":0,"high":32.9,"amplitude":0.061344,"preClose":32.44,"low":30.91,"week52Low":5.35,"pbRate":"5.97","psRate":"8.95","week52High":38.693,"institutionHeld":0,"latestPrice":32.22,"eps":0.684705,"divideRate":0,"volume":572660,"delay":0,"ttmEps":0.684705,"open":32.49,"prevYearClose":31.74,"prevWeekClose":32.4,"prevMonthClose":30.34,"prevQuarterClose":31.74,"fiveDayClose":32,"twentyDayClose":30.58,"sixtyDayClose":26.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STOK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"STOK","fiscalQuarterEnding":"2025/09","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2025-08-12","symbol":"STOK","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2025-05-13","symbol":"STOK","fiscalQuarterEnding":"2025/03","expectedEps":-0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":1.9},{"market":"US","date":"2025-03-18","symbol":"STOK","fiscalQuarterEnding":"2024/12","expectedEps":-0.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-11-05","symbol":"STOK","fiscalQuarterEnding":"2024/09","expectedEps":-0.52,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STOK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STOK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.5455,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1770354000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/STOK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"STOK","date":"2026-02-10","current":47.056762,"percent":0.984565,"low":-47.790686,"twenty":-9.628188,"median":-5.37405,"eighty":-2.034115,"high":49.58873,"avg":-3.046863,"sd":15.683339,"marketCap":1827177628},"quantilePoints":[{"date":"2021-02-12","current":-45.84754,"twenty":-45.934525,"median":-31.243498,"eighty":-22.896211,"marketCap":2193438000},{"date":"2021-02-19","current":-46.559007,"twenty":-46.038592,"median":-31.359797,"eighty":-22.922076,"marketCap":2227476000},{"date":"2021-02-26","current":-45.816939,"twenty":-46.038592,"median":-31.434051,"eighty":-23.013868,"marketCap":2191974000},{"date":"2021-03-05","current":-41.318632,"twenty":-46.038592,"median":-31.485497,"eighty":-23.051364,"marketCap":1976766000},{"date":"2021-03-12","current":-35.974554,"twenty":-45.939621,"median":-31.635776,"eighty":-23.080394,"marketCap":1879418630},{"date":"2021-03-19","current":-33.616487,"twenty":-45.915607,"median":-31.87549,"eighty":-23.091653,"marketCap":1756226149},{"date":"2021-03-26","current":-26.528251,"twenty":-45.896183,"median":-31.744012,"eighty":-23.132204,"marketCap":1385915416},{"date":"2021-04-01","current":-27.602014,"twenty":-45.87655,"median":-31.557807,"eighty":-23.163958,"marketCap":1442011992},{"date":"2021-04-09","current":-24.107022,"twenty":-45.84754,"median":-31.454527,"eighty":-23.181487,"marketCap":1259423136},{"date":"2021-04-16","current":-21.692811,"twenty":-45.816939,"median":-31.396924,"eighty":-23.163958,"marketCap":1133297500},{"date":"2021-04-23","current":-22.16302,"twenty":-45.778688,"median":-31.304106,"eighty":-23.079618,"marketCap":1157862667},{"date":"2021-04-30","current":-22.692273,"twenty":-45.694536,"median":-31.21129,"eighty":-23.044301,"marketCap":1185512423},{"date":"2021-05-07","current":-22.804681,"twenty":-45.497843,"median":-30.984576,"eighty":-22.832783,"marketCap":1191384930},{"date":"2021-05-14","current":-22.582625,"twenty":-45.384231,"median":-30.946358,"eighty":-22.804681,"marketCap":1309724527},{"date":"2021-05-21","current":-23.494032,"twenty":-45.369083,"median":-30.920463,"eighty":-22.692273,"marketCap":1362583365},{"date":"2021-05-28","current":-25.101651,"twenty":-45.365578,"median":-30.889524,"eighty":-22.69687,"marketCap":1455820481},{"date":"2021-06-04","current":-23.607958,"twenty":-45.341098,"median":-30.798661,"eighty":-22.727596,"marketCap":1369190719},{"date":"2021-06-11","current":-23.867455,"twenty":-45.206455,"median":-30.598697,"eighty":-22.7908,"marketCap":1384240805},{"date":"2021-06-18","current":-24.513035,"twenty":-45.137603,"median":-30.456377,"eighty":-22.807602,"marketCap":1421682481},{"date":"2021-06-25","current":-21.683877,"twenty":-44.922858,"median":-30.334021,"eighty":-22.7908,"marketCap":1257599840},{"date":"2021-07-02","current":-21.380075,"twenty":-44.833289,"median":-30.262289,"eighty":-22.68569,"marketCap":1239980228},{"date":"2021-07-09","current":-21.690207,"twenty":-44.799997,"median":-30.19649,"eighty":-22.613151,"marketCap":1257966916},{"date":"2021-07-16","current":-21.107919,"twenty":-44.729083,"median":-29.948732,"eighty":-22.589619,"marketCap":1224195992},{"date":"2021-07-23","current":-19.405361,"twenty":-44.692362,"median":-29.825221,"eighty":-22.480345,"marketCap":1125452747},{"date":"2021-07-30","current":-18.120532,"twenty":-44.687772,"median":-29.775462,"eighty":-22.359425,"marketCap":1050936469},{"date":"2021-08-06","current":-16.557216,"twenty":-44.654519,"median":-29.577709,"eighty":-22.307852,"marketCap":960268880},{"date":"2021-08-13","current":-14.111694,"twenty":-44.59109,"median":-29.54677,"eighty":-22.254342,"marketCap":945554085},{"date":"2021-08-20","current":-13.656478,"twenty":-44.543668,"median":-29.503455,"eighty":-22.207566,"marketCap":915052341},{"date":"2021-08-27","current":-14.846621,"twenty":-44.526954,"median":-29.418862,"eighty":-22.164972,"marketCap":994797866},{"date":"2021-09-03","current":-13.903282,"twenty":-44.48119,"median":-29.33724,"eighty":-22.062723,"marketCap":931589431},{"date":"2021-09-10","current":-13.371283,"twenty":-44.428422,"median":-29.280694,"eighty":-22.006338,"marketCap":895942814},{"date":"2021-09-17","current":-13.842952,"twenty":-44.292111,"median":-29.14762,"eighty":-21.900078,"marketCap":927547031},{"date":"2021-09-24","current":-14.259777,"twenty":-44.112216,"median":-29.107436,"eighty":-21.816956,"marketCap":955476340},{"date":"2021-10-01","current":-14.391405,"twenty":-44.033664,"median":-28.965117,"eighty":-21.778624,"marketCap":964296121},{"date":"2021-10-08","current":-12.35116,"twenty":-43.917823,"median":-28.859924,"eighty":-21.732978,"marketCap":827589506},{"date":"2021-10-15","current":-12.899613,"twenty":-43.714891,"median":-28.605486,"eighty":-21.683229,"marketCap":864338596},{"date":"2021-10-22","current":-13.321922,"twenty":-43.54306,"median":-28.204016,"eighty":-21.573681,"marketCap":892635396},{"date":"2021-10-29","current":-12.521181,"twenty":-43.424579,"median":-27.929317,"eighty":-21.472465,"marketCap":838981724},{"date":"2021-11-05","current":-14.243323,"twenty":-43.031319,"median":-27.602014,"eighty":-21.410904,"marketCap":954373867},{"date":"2021-11-12","current":-13.772755,"twenty":-42.574405,"median":-27.542533,"eighty":-21.319315,"marketCap":1045600021},{"date":"2021-11-19","current":-13.472294,"twenty":-42.387902,"median":-27.486231,"eighty":-21.143231,"marketCap":1022789605},{"date":"2021-11-26","current":-12.16868,"twenty":-42.293788,"median":-27.258129,"eighty":-21.059818,"marketCap":923821834},{"date":"2021-12-03","current":-9.842528,"twenty":-42.209886,"median":-26.993526,"eighty":-20.885249,"marketCap":747225067},{"date":"2021-12-10","current":-9.634144,"twenty":-41.8626,"median":-26.787528,"eighty":-20.739762,"marketCap":731404940},{"date":"2021-12-17","current":-9.517836,"twenty":-41.277733,"median":-26.584041,"eighty":-20.6584,"marketCap":722575102},{"date":"2021-12-23","current":-10.453143,"twenty":-41.114139,"median":-26.442355,"eighty":-20.527969,"marketCap":793581719},{"date":"2021-12-31","current":-11.625911,"twenty":-39.969932,"median":-26.056166,"eighty":-20.39445,"marketCap":882615922},{"date":"2022-01-07","current":-9.794067,"twenty":-39.453682,"median":-26.004313,"eighty":-20.306807,"marketCap":743545968},{"date":"2022-01-14","current":-9.516873,"twenty":-39.385514,"median":-25.910662,"eighty":-20.184107,"marketCap":722502000},{"date":"2022-01-21","current":-8.797518,"twenty":-39.345887,"median":-25.609189,"eighty":-19.999347,"marketCap":667890000},{"date":"2022-01-28","current":-8.71489,"twenty":-39.254422,"median":-25.498438,"eighty":-19.582982,"marketCap":661617000},{"date":"2022-02-04","current":-8.355212,"twenty":-39.131023,"median":-25.321145,"eighty":-18.331927,"marketCap":634311000},{"date":"2022-02-11","current":-8.802379,"twenty":-38.826543,"median":-25.201362,"eighty":-17.440774,"marketCap":668259000},{"date":"2022-02-18","current":-9.20094,"twenty":-38.645867,"median":-25.060611,"eighty":-16.235938,"marketCap":698517000},{"date":"2022-02-25","current":-9.531455,"twenty":-38.57569,"median":-24.928134,"eighty":-14.844427,"marketCap":723609000},{"date":"2022-03-04","current":-9.307872,"twenty":-38.538127,"median":-24.813055,"eighty":-14.56362,"marketCap":706635000},{"date":"2022-03-11","current":-8.89951,"twenty":-38.262435,"median":-24.712,"eighty":-14.378242,"marketCap":763622415},{"date":"2022-03-18","current":-11.363855,"twenty":-37.929498,"median":-24.566833,"eighty":-14.263067,"marketCap":975075589},{"date":"2022-03-25","current":-10.005417,"twenty":-37.628511,"median":-24.46873,"eighty":-14.243323,"marketCap":858514829},{"date":"2022-04-01","current":-9.496003,"twenty":-37.471607,"median":-24.452908,"eighty":-14.186284,"marketCap":814804544},{"date":"2022-04-08","current":-9.9314,"twenty":-37.414177,"median":-24.373792,"eighty":-14.032717,"marketCap":852163762},{"date":"2022-04-14","current":-8.85597,"twenty":-37.36823,"median":-24.241963,"eighty":-13.923026,"marketCap":759886494},{"date":"2022-04-22","current":-7.471408,"twenty":-37.301111,"median":-24.170978,"eighty":-13.824095,"marketCap":641084180},{"date":"2022-04-29","current":-6.587415,"twenty":-37.214766,"median":-24.078949,"eighty":-13.730261,"marketCap":565233136},{"date":"2022-05-06","current":-6.140347,"twenty":-36.919244,"median":-24.041252,"eighty":-13.660343,"marketCap":526872438},{"date":"2022-05-13","current":-6.230287,"twenty":-36.528364,"median":-23.867455,"eighty":-13.502912,"marketCap":583534930},{"date":"2022-05-20","current":-5.912287,"twenty":-36.492045,"median":-23.754294,"eighty":-13.341666,"marketCap":553750743},{"date":"2022-05-27","current":-5.029419,"twenty":-36.438488,"median":-23.668814,"eighty":-13.189197,"marketCap":471060434},{"date":"2022-06-03","current":-5.113103,"twenty":-36.395935,"median":-23.607958,"eighty":-13.129964,"marketCap":478898378},{"date":"2022-06-10","current":-4.723972,"twenty":-36.334792,"median":-23.569159,"eighty":-12.979687,"marketCap":442451938},{"date":"2022-06-17","current":-4.744893,"twenty":-36.288283,"median":-23.494032,"eighty":-12.90071,"marketCap":444411424},{"date":"2022-06-24","current":-5.690524,"twenty":-36.201253,"median":-23.39482,"eighty":-12.65281,"marketCap":532980192},{"date":"2022-07-01","current":-5.761656,"twenty":-35.974554,"median":-23.265988,"eighty":-12.41149,"marketCap":539642444},{"date":"2022-07-08","current":-6.071287,"twenty":-35.95995,"median":-23.252561,"eighty":-12.262013,"marketCap":568642837},{"date":"2022-07-15","current":-6.318156,"twenty":-35.892776,"median":-23.201693,"eighty":-11.656926,"marketCap":591764772},{"date":"2022-07-22","current":-6.498077,"twenty":-35.866994,"median":-23.184045,"eighty":-11.133543,"marketCap":608616351},{"date":"2022-07-29","current":-6.188445,"twenty":-35.815261,"median":-23.158584,"eighty":-10.825551,"marketCap":579615958},{"date":"2022-08-05","current":-7.025287,"twenty":-35.777413,"median":-23.089961,"eighty":-10.449806,"marketCap":657995398},{"date":"2022-08-12","current":-8.837494,"twenty":-35.740825,"median":-23.044301,"eighty":-10.264043,"marketCap":851457160},{"date":"2022-08-19","current":-7.552784,"twenty":-35.561056,"median":-22.897014,"eighty":-10.108098,"marketCap":727680517},{"date":"2022-08-26","current":-6.374451,"twenty":-35.504672,"median":-22.873769,"eighty":-10.06425,"marketCap":614152896},{"date":"2022-09-02","current":-6.210794,"twenty":-35.494869,"median":-22.831796,"eighty":-9.941718,"marketCap":598385171},{"date":"2022-09-09","current":-6.214886,"twenty":-35.440956,"median":-22.806506,"eighty":-9.872307,"marketCap":598779364},{"date":"2022-09-16","current":-6.411274,"twenty":-35.398984,"median":-22.69687,"eighty":-9.76499,"marketCap":617700634},{"date":"2022-09-23","current":-5.331136,"twenty":-35.365729,"median":-22.677895,"eighty":-9.666853,"marketCap":513633648},{"date":"2022-09-30","current":-5.253399,"twenty":-35.300331,"median":-22.613151,"eighty":-9.594642,"marketCap":506143978},{"date":"2022-10-07","current":-5.118382,"twenty":-35.250852,"median":-22.608539,"eighty":-9.54312,"marketCap":493135605},{"date":"2022-10-14","current":-4.872896,"twenty":-35.18649,"median":-22.582625,"eighty":-9.488797,"marketCap":469484017},{"date":"2022-10-21","current":-5.580714,"twenty":-35.138879,"median":-22.531529,"eighty":-9.399062,"marketCap":537679429},{"date":"2022-10-28","current":-6.419457,"twenty":-35.120969,"median":-22.421059,"eighty":-9.338007,"marketCap":618489020},{"date":"2022-11-04","current":-4.782884,"twenty":-35.074551,"median":-22.356238,"eighty":-9.265181,"marketCap":460811768},{"date":"2022-11-11","current":-5.110199,"twenty":-34.9328,"median":-22.317758,"eighty":-9.213578,"marketCap":492347219},{"date":"2022-11-18","current":-3.162831,"twenty":-34.844878,"median":-22.301953,"eighty":-9.177856,"marketCap":315840283},{"date":"2022-11-25","current":-2.894326,"twenty":-34.802691,"median":-22.267919,"eighty":-9.073075,"marketCap":289027375},{"date":"2022-12-02","current":-2.906172,"twenty":-34.750714,"median":-22.234519,"eighty":-8.973723,"marketCap":290210297},{"date":"2022-12-09","current":-3.040424,"twenty":-34.730913,"median":-22.207225,"eighty":-8.844884,"marketCap":303616751},{"date":"2022-12-16","current":-3.423439,"twenty":-34.699976,"median":-22.186657,"eighty":-8.799462,"marketCap":341864576},{"date":"2022-12-23","current":-3.27734,"twenty":-34.662034,"median":-22.14322,"eighty":-8.749885,"marketCap":327275200},{"date":"2022-12-30","current":-3.64456,"twenty":-34.606761,"median":-22.091871,"eighty":-8.661178,"marketCap":363945794},{"date":"2023-01-06","current":-3.36421,"twenty":-34.602207,"median":-22.053562,"eighty":-8.485883,"marketCap":335949964},{"date":"2023-01-13","current":-3.849888,"twenty":-34.496293,"median":-21.99127,"eighty":-8.189813,"marketCap":384449783},{"date":"2023-01-20","current":-3.763018,"twenty":-34.482019,"median":-21.921681,"eighty":-7.792542,"marketCap":375775018},{"date":"2023-01-27","current":-3.802504,"twenty":-34.455616,"median":-21.879685,"eighty":-7.536509,"marketCap":379718093},{"date":"2023-02-03","current":-3.727481,"twenty":-34.412797,"median":-21.828026,"eighty":-7.073716,"marketCap":372226251},{"date":"2023-02-10","current":-3.648509,"twenty":-34.275355,"median":-21.807536,"eighty":-6.944064,"marketCap":364340102},{"date":"2023-02-17","current":-3.628766,"twenty":-34.183911,"median":-21.765838,"eighty":-6.847483,"marketCap":362368564},{"date":"2023-02-24","current":-3.372107,"twenty":-34.154209,"median":-21.758619,"eighty":-6.753208,"marketCap":336738579},{"date":"2023-03-03","current":-3.486616,"twenty":-34.123566,"median":-21.709714,"eighty":-6.639503,"marketCap":348173496},{"date":"2023-03-10","current":-3.817772,"twenty":-34.108204,"median":-21.683877,"eighty":-6.551201,"marketCap":385850784},{"date":"2023-03-17","current":-3.896399,"twenty":-34.099438,"median":-21.637837,"eighty":-6.431482,"marketCap":393797368},{"date":"2023-03-24","current":-3.341643,"twenty":-34.012915,"median":-21.569952,"eighty":-6.362995,"marketCap":337729805},{"date":"2023-03-31","current":-3.638678,"twenty":-33.936399,"median":-21.531081,"eighty":-6.261528,"marketCap":367750232},{"date":"2023-04-06","current":-3.468319,"twenty":-33.916598,"median":-21.445893,"eighty":-6.235583,"marketCap":350532634},{"date":"2023-04-14","current":-3.809036,"twenty":-33.865701,"median":-21.42438,"eighty":-6.211896,"marketCap":384967830},{"date":"2023-04-21","current":-3.719612,"twenty":-33.769568,"median":-21.370615,"eighty":-6.148887,"marketCap":375930007},{"date":"2023-04-28","current":-3.821042,"twenty":-33.718374,"median":-21.304125,"eighty":-6.104417,"marketCap":386181296},{"date":"2023-05-05","current":-4.78632,"twenty":-33.691231,"median":-21.193209,"eighty":-6.082323,"marketCap":473668592},{"date":"2023-05-12","current":-5.134931,"twenty":-33.656513,"median":-21.107919,"eighty":-6.045345,"marketCap":508168141},{"date":"2023-05-19","current":-4.965255,"twenty":-33.636166,"median":-20.975006,"eighty":-5.926514,"marketCap":491376498},{"date":"2023-05-26","current":-4.737532,"twenty":-33.590004,"median":-20.885249,"eighty":-5.852825,"marketCap":468840345},{"date":"2023-06-02","current":-5.041162,"twenty":-33.544658,"median":-20.867409,"eighty":-5.796984,"marketCap":498888548},{"date":"2023-06-09","current":-5.666284,"twenty":-33.512942,"median":-20.758167,"eighty":-5.744919,"marketCap":560752496},{"date":"2023-06-16","current":-5.773448,"twenty":-33.441374,"median":-20.683862,"eighty":-5.694708,"marketCap":571357744},{"date":"2023-06-23","current":-5.862751,"twenty":-33.302768,"median":-20.657898,"eighty":-5.711445,"marketCap":580195451},{"date":"2023-06-30","current":-4.688415,"twenty":-33.292743,"median":-20.622321,"eighty":-5.614483,"marketCap":463979607},{"date":"2023-07-07","current":-4.474087,"twenty":-33.282905,"median":-20.508385,"eighty":-5.575804,"marketCap":442769110},{"date":"2023-07-14","current":-4.549995,"twenty":-33.263166,"median":-20.425125,"eighty":-5.534872,"marketCap":450281161},{"date":"2023-07-21","current":-4.96972,"twenty":-33.238339,"median":-20.341864,"eighty":-5.46315,"marketCap":491818383},{"date":"2023-07-28","current":-2.741606,"twenty":-33.169061,"median":-20.298043,"eighty":-5.422735,"marketCap":271317598},{"date":"2023-08-04","current":-2.612117,"twenty":-33.122727,"median":-20.201636,"eighty":-5.389445,"marketCap":258502923},{"date":"2023-08-11","current":-2.394903,"twenty":-33.091542,"median":-20.135904,"eighty":-5.364041,"marketCap":251380958},{"date":"2023-08-18","current":-2.344306,"twenty":-33.06266,"median":-19.995508,"eighty":-5.337776,"marketCap":246070093},{"date":"2023-08-25","current":-2.365388,"twenty":-33.05389,"median":-19.66511,"eighty":-5.314277,"marketCap":248282953},{"date":"2023-09-01","current":-2.369604,"twenty":-32.972678,"median":-19.33574,"eighty":-5.23025,"marketCap":248725525},{"date":"2023-09-08","current":-2.272628,"twenty":-32.909235,"median":-18.348383,"eighty":-5.201346,"marketCap":238546367},{"date":"2023-09-15","current":-2.137704,"twenty":-32.874572,"median":-18.186988,"eighty":-5.115215,"marketCap":224384059},{"date":"2023-09-22","current":-1.751098,"twenty":-32.820119,"median":-16.974944,"eighty":-5.077645,"marketCap":183803977},{"date":"2023-09-29","current":-1.595084,"twenty":-32.773909,"median":-16.617344,"eighty":-5.045839,"marketCap":167427974},{"date":"2023-10-06","current":-1.603523,"twenty":-32.582617,"median":-14.887369,"eighty":-5.030544,"marketCap":168313837},{"date":"2023-10-13","current":-1.654161,"twenty":-32.215752,"median":-14.83291,"eighty":-5.002311,"marketCap":173629010},{"date":"2023-10-20","current":-1.561325,"twenty":-32.041872,"median":-14.583364,"eighty":-4.962576,"marketCap":163884525},{"date":"2023-10-27","current":-1.46005,"twenty":-32.018537,"median":-14.534003,"eighty":-4.952066,"marketCap":153254177},{"date":"2023-11-03","current":-1.738557,"twenty":-31.910936,"median":-14.391405,"eighty":-4.875341,"marketCap":182487633},{"date":"2023-11-10","current":-1.956378,"twenty":-31.881049,"median":-14.320107,"eighty":-4.785633,"marketCap":202281632},{"date":"2023-11-17","current":-1.800904,"twenty":-31.873039,"median":-14.262519,"eighty":-4.759857,"marketCap":186206270},{"date":"2023-11-24","current":-1.736123,"twenty":-31.79497,"median":-14.259777,"eighty":-4.732108,"marketCap":179508203},{"date":"2023-12-01","current":-1.636793,"twenty":-31.67907,"median":-14.243323,"eighty":-4.676805,"marketCap":169237833},{"date":"2023-12-08","current":-1.986609,"twenty":-31.588995,"median":-14.204932,"eighty":-4.574107,"marketCap":205407397},{"date":"2023-12-15","current":-2.219819,"twenty":-31.520717,"median":-14.111694,"eighty":-4.523204,"marketCap":229520439},{"date":"2023-12-22","current":-2.228457,"twenty":-31.483398,"median":-14.026684,"eighty":-4.474087,"marketCap":230413515},{"date":"2023-12-29","current":-2.332106,"twenty":-31.466813,"median":-13.98555,"eighty":-4.371661,"marketCap":241130422},{"date":"2024-01-05","current":-2.271644,"twenty":-31.442241,"median":-13.927962,"eighty":-4.330886,"marketCap":234878893},{"date":"2024-01-12","current":-2.260847,"twenty":-31.434051,"median":-13.85514,"eighty":-4.251665,"marketCap":233762548},{"date":"2024-01-19","current":-2.098895,"twenty":-31.411775,"median":-13.811524,"eighty":-4.073662,"marketCap":217017380},{"date":"2024-01-26","current":-2.090258,"twenty":-31.382073,"median":-13.75337,"eighty":-3.97852,"marketCap":216124304},{"date":"2024-02-02","current":-2.111851,"twenty":-31.357321,"median":-13.714601,"eighty":-3.939686,"marketCap":218356993},{"date":"2024-02-09","current":-1.895916,"twenty":-31.295444,"median":-13.661309,"eighty":-3.892488,"marketCap":196030102},{"date":"2024-02-16","current":-2.293237,"twenty":-31.240039,"median":-13.544986,"eighty":-3.83835,"marketCap":237111582},{"date":"2024-02-23","current":-2.297556,"twenty":-31.220238,"median":-13.502912,"eighty":-3.809582,"marketCap":237558120},{"date":"2024-03-01","current":-3.342685,"twenty":-31.151958,"median":-13.383019,"eighty":-3.763139,"marketCap":345620272},{"date":"2024-03-08","current":-3.303817,"twenty":-31.034976,"median":-13.245139,"eighty":-3.736958,"marketCap":341601432},{"date":"2024-03-15","current":-2.798527,"twenty":-30.986261,"median":-13.190293,"eighty":-3.705369,"marketCap":289356507},{"date":"2024-03-22","current":-2.58691,"twenty":-30.971203,"median":-13.151902,"eighty":-3.67299,"marketCap":267476154},{"date":"2024-03-28","current":-7.018656,"twenty":-30.960293,"median":-13.05318,"eighty":-3.665093,"marketCap":734846281},{"date":"2024-04-05","current":-6.02802,"twenty":-30.945081,"median":-12.99285,"eighty":-3.670621,"marketCap":631127681},{"date":"2024-04-12","current":-6.686793,"twenty":-30.93731,"median":-12.914987,"eighty":-3.680888,"marketCap":700100550},{"date":"2024-04-19","current":-5.770455,"twenty":-30.924176,"median":-12.820087,"eighty":-3.684836,"marketCap":604160845},{"date":"2024-04-26","current":-5.819096,"twenty":-30.910287,"median":-12.65281,"eighty":-3.691154,"marketCap":609253563},{"date":"2024-05-03","current":-5.819096,"twenty":-30.893373,"median":-12.47182,"eighty":-3.704579,"marketCap":609253563},{"date":"2024-05-10","current":-5.767724,"twenty":-30.874461,"median":-12.35116,"eighty":-3.709317,"marketCap":625959518},{"date":"2024-05-17","current":-6.737815,"twenty":-30.811099,"median":-12.227013,"eighty":-3.71643,"marketCap":731241635},{"date":"2024-05-24","current":-7.064381,"twenty":-30.767331,"median":-12.066911,"eighty":-3.721186,"marketCap":766683140},{"date":"2024-05-31","current":-6.617755,"twenty":-30.642011,"median":-11.625911,"eighty":-3.727481,"marketCap":718211670},{"date":"2024-06-07","current":-7.304503,"twenty":-30.629636,"median":-11.257422,"eighty":-3.751173,"marketCap":792743070},{"date":"2024-06-14","current":-8.413993,"twenty":-30.580134,"median":-11.024988,"eighty":-3.757491,"marketCap":913153823},{"date":"2024-06-21","current":-7.088501,"twenty":-30.436216,"median":-10.782215,"eighty":-3.75986,"marketCap":769300823},{"date":"2024-06-28","current":-6.392137,"twenty":-30.285472,"median":-10.453143,"eighty":-3.755911,"marketCap":693725878},{"date":"2024-07-05","current":-6.084777,"twenty":-30.066396,"median":-10.284071,"eighty":-3.755911,"marketCap":660368660},{"date":"2024-07-12","current":-6.737918,"twenty":-29.788387,"median":-10.10422,"eighty":-3.755911,"marketCap":731252747},{"date":"2024-07-15","current":-6.843573,"twenty":-29.774488,"median":-10.100134,"eighty":-3.755911,"marketCap":742719291},{"date":"2024-08-02","current":-7.069291,"twenty":-29.379699,"median":-9.9314,"eighty":-3.719612,"marketCap":767215997},{"date":"2024-08-09","current":-7.187864,"twenty":-29.150676,"median":-9.779528,"eighty":-3.719612,"marketCap":744439877},{"date":"2024-08-16","current":-7.243781,"twenty":-28.98368,"median":-9.666678,"eighty":-3.719612,"marketCap":750231135},{"date":"2024-08-23","current":-6.989613,"twenty":-28.674289,"median":-9.570756,"eighty":-3.719612,"marketCap":723907236},{"date":"2024-08-30","current":-7.065863,"twenty":-27.96888,"median":-9.517354,"eighty":-3.719612,"marketCap":731804406},{"date":"2024-09-06","current":-7.701283,"twenty":-27.594995,"median":-9.422093,"eighty":-3.719612,"marketCap":797614154},{"date":"2024-09-13","current":-6.96928,"twenty":-27.347221,"median":-9.346756,"eighty":-3.719612,"marketCap":721801324},{"date":"2024-09-20","current":-7.696199,"twenty":-26.849716,"median":-9.263015,"eighty":-3.719612,"marketCap":797087676},{"date":"2024-09-27","current":-6.232193,"twenty":-26.499908,"median":-9.209172,"eighty":-3.719612,"marketCap":645462015},{"date":"2024-10-04","current":-6.003442,"twenty":-26.006729,"median":-9.125602,"eighty":-3.719612,"marketCap":621770506},{"date":"2024-10-11","current":-5.795025,"twenty":-25.609189,"median":-8.975949,"eighty":-3.719612,"marketCap":600184908},{"date":"2024-10-18","current":-6.745612,"twenty":-25.321145,"median":-8.827227,"eighty":-3.719612,"marketCap":698636292},{"date":"2024-10-25","current":-6.125443,"twenty":-25.060611,"median":-8.776249,"eighty":-3.719612,"marketCap":634405977},{"date":"2024-10-31","current":-6.354194,"twenty":-24.820829,"median":-8.695448,"eighty":-3.719612,"marketCap":658097487},{"date":"2024-11-08","current":-6.665008,"twenty":-24.534554,"median":-8.413993,"eighty":-3.718817,"marketCap":702871784},{"date":"2024-11-15","current":-6.991478,"twenty":-24.451009,"median":-8.220291,"eighty":-3.718817,"marketCap":737300319},{"date":"2024-11-22","current":-5.660486,"twenty":-24.22794,"median":-7.880795,"eighty":-3.718817,"marketCap":596937830},{"date":"2024-11-29","current":-6.082385,"twenty":-24.084564,"median":-7.80295,"eighty":-3.718817,"marketCap":641430091},{"date":"2024-12-06","current":-6.313425,"twenty":-23.886472,"median":-7.696199,"eighty":-3.718817,"marketCap":665794900},{"date":"2024-12-13","current":-6.18786,"twenty":-23.669286,"median":-7.592649,"eighty":-3.718817,"marketCap":652553156},{"date":"2024-12-20","current":-5.675553,"twenty":-23.559869,"median":-7.492865,"eighty":-3.718817,"marketCap":598526840},{"date":"2024-12-27","current":-5.645418,"twenty":-23.39535,"median":-7.472532,"eighty":-3.718817,"marketCap":595348821},{"date":"2025-01-03","current":-5.660486,"twenty":-23.255824,"median":-7.396281,"eighty":-3.718817,"marketCap":596937830},{"date":"2025-01-10","current":-4.500262,"twenty":-23.187025,"median":-7.330603,"eighty":-3.718021,"marketCap":474584113},{"date":"2025-01-17","current":-4.751393,"twenty":-23.107559,"median":-7.205656,"eighty":-3.718021,"marketCap":501067602},{"date":"2025-01-24","current":-5.32397,"twenty":-23.021476,"median":-7.124016,"eighty":-3.718021,"marketCap":561449956},{"date":"2025-01-31","current":-5.519852,"twenty":-22.869972,"median":-7.072416,"eighty":-3.718021,"marketCap":582107077},{"date":"2025-02-07","current":-6.39881,"twenty":-22.763039,"median":-7.041893,"eighty":-3.718021,"marketCap":674799286},{"date":"2025-02-14","current":-5.339038,"twenty":-22.634525,"median":-6.990545,"eighty":-3.718021,"marketCap":563038965},{"date":"2025-02-21","current":-4.389764,"twenty":-22.607913,"median":-6.975417,"eighty":-3.718021,"marketCap":462931378},{"date":"2025-02-28","current":-4.013068,"twenty":-22.529197,"median":-6.940328,"eighty":-3.718021,"marketCap":423206146},{"date":"2025-03-07","current":-4.09343,"twenty":-22.332147,"median":-6.88588,"eighty":-3.716075,"marketCap":431680862},{"date":"2025-03-14","current":-4.07334,"twenty":-22.288306,"median":-6.838321,"eighty":-3.716075,"marketCap":429562183},{"date":"2025-03-21","current":-5.062514,"twenty":-22.224283,"median":-6.746772,"eighty":-3.716075,"marketCap":450467565},{"date":"2025-03-28","current":-4.527699,"twenty":-22.208928,"median":-6.733396,"eighty":-3.716075,"marketCap":402879155},{"date":"2025-04-04","current":-3.828792,"twenty":-22.203776,"median":-6.669629,"eighty":-3.716075,"marketCap":340689755},{"date":"2025-04-11","current":-3.962496,"twenty":-22.192456,"median":-6.659591,"eighty":-3.697471,"marketCap":352586858},{"date":"2025-04-17","current":-4.594551,"twenty":-22.090423,"median":-6.621515,"eighty":-3.697471,"marketCap":408827706},{"date":"2025-04-25","current":-6.004519,"twenty":-22.013871,"median":-6.587415,"eighty":-3.694313,"marketCap":534288061},{"date":"2025-05-02","current":-6.05603,"twenty":-21.895426,"median":-6.521805,"eighty":-3.694313,"marketCap":538871639},{"date":"2025-05-09","current":-5.552895,"twenty":-21.802419,"median":-6.486361,"eighty":-3.694313,"marketCap":494102162},{"date":"2025-05-16","current":10.458473,"twenty":-21.691769,"median":-6.439498,"eighty":-3.67299,"marketCap":525768378},{"date":"2025-05-23","current":10.31729,"twenty":-21.594061,"median":-6.414062,"eighty":-3.652052,"marketCap":518670778},{"date":"2025-05-30","current":10.567077,"twenty":-21.535694,"median":-6.392137,"eighty":-3.641031,"marketCap":531228070},{"date":"2025-06-06","current":11.816012,"twenty":-21.364885,"median":-6.36436,"eighty":-3.616232,"marketCap":594014533},{"date":"2025-06-13","current":12.83688,"twenty":-21.21425,"median":-6.325211,"eighty":-3.571116,"marketCap":645335641},{"date":"2025-06-20","current":12.565373,"twenty":-21.243365,"median":-6.308393,"eighty":-3.558481,"marketCap":631686410},{"date":"2025-06-27","current":12.858601,"twenty":-21.123109,"median":-6.254659,"eighty":-3.54128,"marketCap":646427580},{"date":"2025-07-03","current":12.46763,"twenty":-21.123109,"median":-6.242943,"eighty":-3.512001,"marketCap":626772687},{"date":"2025-07-11","current":13.075807,"twenty":-21.123109,"median":-6.220501,"eighty":-3.487325,"marketCap":657346964},{"date":"2025-07-18","current":13.412476,"twenty":-21.024374,"median":-6.208749,"eighty":-3.464825,"marketCap":674272011},{"date":"2025-07-25","current":14.672272,"twenty":-20.62057,"median":-6.174174,"eighty":-3.438597,"marketCap":737604443},{"date":"2025-08-01","current":13.955492,"twenty":-19.266119,"median":-6.143731,"eighty":-3.381584,"marketCap":701570473},{"date":"2025-08-08","current":14.389904,"twenty":-18.007872,"median":-6.121067,"eighty":-3.316827,"marketCap":723409243},{"date":"2025-08-15","current":17.860897,"twenty":-16.235938,"median":-6.08846,"eighty":-3.27734,"marketCap":937429185},{"date":"2025-08-22","current":20.547074,"twenty":-14.809326,"median":-6.07657,"eighty":-3.258387,"marketCap":1078413186},{"date":"2025-08-29","current":20.641039,"twenty":-14.391405,"median":-6.062607,"eighty":-3.170728,"marketCap":1083344953},{"date":"2025-09-05","current":20.494871,"twenty":-14.265261,"median":-6.047833,"eighty":-3.040424,"marketCap":1075673315},{"date":"2025-09-12","current":24.93212,"twenty":-14.243323,"median":-6.023327,"eighty":-2.96734,"marketCap":1308562341},{"date":"2025-09-19","current":24.535378,"twenty":-14.168733,"median":-5.992531,"eighty":-2.899854,"marketCap":1287739323},{"date":"2025-09-26","current":23.961146,"twenty":-13.978969,"median":-5.936583,"eighty":-2.872489,"marketCap":1257600743},{"date":"2025-10-03","current":25.913536,"twenty":-13.836666,"median":-5.914379,"eighty":-2.82389,"marketCap":1360071914},{"date":"2025-10-10","current":31.217353,"twenty":-13.725142,"median":-5.892835,"eighty":-2.745217,"marketCap":1638442798},{"date":"2025-10-17","current":35.675484,"twenty":-13.587632,"median":-5.843541,"eighty":-2.591951,"marketCap":1872427773},{"date":"2025-10-24","current":33.086218,"twenty":-13.390061,"median":-5.819096,"eighty":-2.510037,"marketCap":1736530176},{"date":"2025-10-31","current":33.096659,"twenty":-13.193584,"median":-5.795025,"eighty":-2.42779,"marketCap":1737078150},{"date":"2025-11-07","current":31.637103,"twenty":-13.050986,"median":-5.77655,"eighty":-2.367246,"marketCap":1283422360},{"date":"2025-11-14","current":36.705798,"twenty":-12.913009,"median":-5.766842,"eighty":-2.345149,"marketCap":1489044100},{"date":"2025-11-21","current":39.324623,"twenty":-12.646228,"median":-5.741976,"eighty":-2.316558,"marketCap":1595281999},{"date":"2025-11-28","current":43.520376,"twenty":-12.399424,"median":-5.733237,"eighty":-2.301928,"marketCap":1765491106},{"date":"2025-12-05","current":43.717492,"twenty":-12.109557,"median":-5.688061,"eighty":-2.293332,"marketCap":1773487507},{"date":"2025-12-12","current":46.589753,"twenty":-11.321282,"median":-5.663385,"eighty":-2.271841,"marketCap":1890006493},{"date":"2025-12-19","current":44.956506,"twenty":-10.825551,"median":-5.601739,"eighty":-2.252209,"marketCap":1823750599},{"date":"2025-12-26","current":45.294419,"twenty":-10.449806,"median":-5.580419,"eighty":-2.233156,"marketCap":1837458715},{"date":"2026-01-02","current":44.688992,"twenty":-10.264043,"median":-5.566012,"eighty":-2.212909,"marketCap":1812898341},{"date":"2026-01-09","current":47.420455,"twenty":-10.103403,"median":-5.543378,"eighty":-2.151584,"marketCap":1923705612},{"date":"2026-01-16","current":41.225384,"twenty":-10.034059,"median":-5.517551,"eighty":-2.129126,"marketCap":1672390152},{"date":"2026-01-23","current":42.309521,"twenty":-9.92041,"median":-5.486539,"eighty":-2.102351,"marketCap":1716370357},{"date":"2026-01-30","current":43.745652,"twenty":-9.76499,"median":-5.423579,"eighty":-2.091122,"marketCap":1774629850},{"date":"2026-02-06","current":42.914949,"twenty":-9.664066,"median":-5.394535,"eighty":-2.060027,"marketCap":1740930732},{"date":"2026-02-10","current":45.040985,"twenty":-9.628188,"median":-5.37405,"eighty":-2.034115,"marketCap":1827177628}],"updateTime":1770848275137},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"STOK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610599950","title":"High Growth Tech Stocks In The US February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610599950","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610599950?lang=en_us&edition=fundamental","pubTime":"2026-02-12 01:08","pubTimestamp":1770829713,"startTime":"0","endTime":"0","summary":"As February 2026 begins, the U.S. stock market has seen a robust start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, reflecting positive investor sentiment despite recent economic uncertainties such as government shutdowns and changes in Federal Reserve leadership. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of factors such as innovation potential, adaptability to market shifts, and financial...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/high-growth-tech-stocks-in-the-us-february-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/high-growth-tech-stocks-in-the-us-february-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4613","CRC","BK4543","PLTG","BK4588","WDAY","PLTW","MRKR","LU1861559042.SGD","BK4023","BK4585","BK4547","IE00BZ9MQY76.HKD","PLYY","PLTU","PLTD","PCOR","PLTZ","VRDN","PLTA","PLOO","IE00B894F039.SGD","PTIR","SNDK","PLT","IE00B19Z9Z06.USD","PLTY","IE00B19Z9P08.USD","BK4009","BK4139","STOK","LU1861558580.USD","PLTR","RDDT","MNTN"],"gpt_icon":0},{"id":"2610558199","title":"Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2610558199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610558199?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:12","pubTimestamp":1770819120,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics  said Wednesday that the first patient has received a dose in an early-stage trial of STK-002 for the treatment of Autosomal Dominant Optic Atrophy, an inherited vision loss condition.The open-label study's primary objective will be to evaluate the safety and tolerability of the investigational medicine in patients between the ages of 6 and 55, the company said.Researchers plan to monitor changes in visual function, eye structure, and quality of life as secondary goals of the clinical program, the company added.Stoke Therapeutics said the trial is currently enrolling participants with a confirmed genetic mutation linked to the condition in Germany and the UK, with additional European sites expected to activate in the coming months.The company also said the dose escalation for the initial four groups is expected to continue through this year and into early next year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSI","LENZ","BK4139","BK4539","BK4007","STOK"],"gpt_icon":0},{"id":"2610937612","title":"BRIEF-Stoke Therapeutics Announces First Patient Dosed In Phase 1 Study Of Stk-002","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937612","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610937612?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:46","pubTimestamp":1770813997,"startTime":"0","endTime":"0","summary":"BRIEF-Stoke Therapeutics Announces First Patient Dosed In Phase 1 Study Of Stk-002Feb 11 (Reuters) - Stoke Therapeutics Inc STOK.O:STOKE THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 STUDY OF ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA6YHZLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2610932272","title":"Stoke Therapeutics Doses First Patient in Phase 1 Trial of STK-002 for Autosomal Dominant Optic Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932272","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932272?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813040,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. has announced the dosing of the first patient in the Phase 1 OSPREY study of STK-002, an investigational medicine for the treatment of Autosomal Dominant Optic Atrophy . The OSPREY study is a dose-escalating, open-label clinical trial recruiting children and adults aged 6 to 55 with a confirmed diagnosis of ADOA and a disease-causing variant in the OPA1 gene. The primary objectives are to assess the safety and tolerability of single ascending doses of STK-002, as well as drug exposure in blood. Secondary objectives include evaluating changes in visual function, ocular structure, and quality of life. The study is currently recruiting in the United Kingdom and Germany, with additional European sites expected to be added. Dose escalation is planned to continue through 2026 and early 2027, pending safety and tolerability assessments. Clinical results have not yet been presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL5Z3jFm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2610932736","title":"Stoke Therapeutics Inc: Dose Escalation of First Four Cohorts Will Continue Through 2026 and Early 2027, Pending Safety and Tolerability Assessments","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932736?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA6YHZLR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2610932210","title":"Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of Stk-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (Adoa)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932210?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA6YHZLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","STOK"],"gpt_icon":0},{"id":"2609318350","title":"Stoke Therapeutics präsentiert auf dem Guggenheim Emerging Outlook: Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2609318350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609318350?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:01","pubTimestamp":1770238886,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. wird am Mittwoch, den 11. Februar 2026, um 14:30 Uhr  auf dem Guggenheim Emerging Outlook: Biotech Summit 2026 prsentieren. CEO Ian F. Smith stellt das Unternehmen und aktuelle Entwicklungen im Bereich RNA-Medizin vor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8dNm3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STOK"],"gpt_icon":0},{"id":"2608837555","title":"Will Stoke’s New Waltham Headquarters for Zorevunersen Commercialization Shift Stoke Therapeutics' (STOK) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608837555","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608837555?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:11","pubTimestamp":1769994694,"startTime":"0","endTime":"0","summary":"In January 2026, Stoke Therapeutics entered into a long-term lease for a new 98,500 square-foot headquarters and laboratory at 245 Fifth Avenue in Waltham, Massachusetts, with aggregate estimated base rent of about US$85.5 million through March 31, 2038. \nThis expanded facility, backed by a US$3 million security deposit, is intended to support Stoke’s preparations to commercialize its potential Dravet syndrome medicine, zorevunersen, and broaden research based on its proprietary...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/will-stokes-new-waltham-headquarters-for-zorevunersen-commer","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/will-stokes-new-waltham-headquarters-for-zorevunersen-commer","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","STOK"],"gpt_icon":0},{"id":"2606274732","title":"Stoke Therapeutics Signs Lease for New 98,500-Square-Foot Headquarters in Waltham","url":"https://stock-news.laohu8.com/highlight/detail?id=2606274732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606274732?lang=en_us&edition=fundamental","pubTime":"2026-01-28 03:06","pubTimestamp":1769540816,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. has announced plans to relocate its headquarters to a new 98,500 square-foot facility at 245 Fifth Avenue in Waltham, Massachusetts. The move, set for late 2026 when the company’s current Bedford lease ends, will support Stoke’s efforts to commercialize its lead medicine, zorevunersen, for Dravet syndrome and expand research activities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on January 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDLcbNBwW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2606258663","title":"How Accelerated EMPEROR Enrollment and Expedited FDA Talks At Stoke Therapeutics (STOK) Have Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2606258663","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606258663?lang=en_us&edition=fundamental","pubTime":"2026-01-25 07:17","pubTimestamp":1769296659,"startTime":"0","endTime":"0","summary":"Earlier in January 2026, Stoke Therapeutics announced accelerated timelines for completing enrollment in the Phase 3 EMPEROR study of zorevunersen in Dravet syndrome, with enrollment now expected to finish in the second quarter of 2026 and a Phase 3 data readout anticipated in mid-2027 to support a rolling NDA submission.\nAn important insight is the ongoing multidisciplinary dialogue with the FDA under Breakthrough Therapy Designation, which highlights active exploration of expedited...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/how-accelerated-emperor-enrollment-and-expedited-fda-talks-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/how-accelerated-emperor-enrollment-and-expedited-fda-talks-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2605149591","title":"Stoke Therapeutics (STOK) Valuation Check As Phase 3 Dravet Study Advances And FDA Discussions Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2605149591","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605149591?lang=en_us&edition=fundamental","pubTime":"2026-01-22 18:33","pubTimestamp":1769077981,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics (STOK) recently outlined faster enrollment and a clearer data timeline for its Phase 3 EMPEROR study of zorevunersen in Dravet syndrome, along with ongoing FDA discussions on potential expedited review options.\nSee our latest analysis for Stoke Therapeutics.\nThe latest Dravet syndrome update comes after a mixed period for the shares, with a 1 day share price return of 2.72% contrasting with a 30 day share price return decline of 11.99%. The 1 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/stoke-therapeutics-stok-valuation-check-as-phase-3-dravet-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-stok/stoke-therapeutics/news/stoke-therapeutics-stok-valuation-check-as-phase-3-dravet-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4097","STOK","LU2065732104.USD","PRGS","DCF"],"gpt_icon":0},{"id":"2604919566","title":"Stoke Therapeutics Grants Stock Options to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2604919566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604919566?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:01","pubTimestamp":1768597273,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. has granted stock options to purchase a total of 74,020 shares of common stock to nine new employees. The options have an exercise price of $29.28 per share, matching the closing price of the company's stock on January 15, 2026. Each option vests over four years, with one-quarter vesting on the first anniversary of the vesting commencement date and the remaining shares vesting monthly over the subsequent 36 months. The options have a ten-year term and are issued under the company's 2023 Inducement Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on January 16, 2026, and is solely responsible for the inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL6HYXr8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2604191958","title":"Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191958?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:01","pubTimestamp":1768597260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nTUA3NQ0KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","STOK"],"gpt_icon":0},{"id":"2603654724","title":"Stoke Therapeutics Down Over 16%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2603654724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603654724?lang=en_us&edition=fundamental","pubTime":"2026-01-13 01:39","pubTimestamp":1768239540,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics, Inc.  is currently at $27.44, down $5.41 or 16.47%. --Would be lowest close since Nov. 17, 2025, when it closed at $26.95. --On pace for largest percent decrease since Feb. 13, 2024, when it fell 17.27%. --Currently down four consecutive days; down 22.09% over this period. --Longest losing streak since Nov. 6, 2025, when it fell for five straight trading days. --Down 60.69% from its all-time closing high of $69.81 on Jan. 19, 2021. --Up 207.62% from 52 weeks ago , when it closed at $8.92. --Down 22.92% from its 52-week closing high of $35.60 on Oct. 15, 2025. --Up 365.08% from its 52-week closing low of $5.90 on April 8, 2025. --Traded as low as $25.21; lowest intraday level since Nov. 13, 2025, when it hit $24.34. --Down 23.26% at today's intraday low; largest intraday percent decrease since July 25, 2023, when it fell as much as 35.83%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4139","BK4007","STOK"],"gpt_icon":0},{"id":"2603542882","title":"Stoke Therapeutics to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542882","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542882?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:25","pubTimestamp":1768235140,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 4:30pm Pacific Time in San Francisco, CA. A live audio webcast of the presentation will be available on the Investors & News section of Stoke's website, with a replay accessible for 30 days following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL1ShlxR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2602550414","title":"Stoke Therapeutics updates timeline for Phase 3 EMPEROR study","url":"https://stock-news.laohu8.com/highlight/detail?id=2602550414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602550414?lang=en_us&edition=fundamental","pubTime":"2026-01-12 03:55","pubTimestamp":1768161307,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics (STOK) announced accelerated timelines for the completion of enrollment and a Phase 3 data readout from the EMPEROR study. Compl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/stoke-therapeutics-updates-timeline-for-phase-3-emperor-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/stoke-therapeutics-updates-timeline-for-phase-3-emperor-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","STOK","BK4139","LENZ"],"gpt_icon":0},{"id":"2602557755","title":"Stoke Therapeutics Showcases Pipeline Advancements for Dravet Syndrome and Rare Genetic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557755","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602557755?lang=en_us&edition=fundamental","pubTime":"2026-01-12 03:04","pubTimestamp":1768158255,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. presented updates on its pipeline of RNA-based medicines targeting diseases caused by protein insufficiency. The company highlighted progress in its lead program, zorevunersen, for Dravet syndrome, noting that Phase 3 enrollment is underway with completion expected in the second quarter of 2026 and a data readout anticipated in mid-2027 to support a potential NDA filing. Additional updates included the initiation of a Phase 1 study of STK-002 for Autosomal Dominant Optic Atrophy  in the UK and Europe, and ongoing lead optimization to identify a clinical candidate for SYNGAP1-related disorders in 2026. Stoke reported a strong balance sheet with approximately $391.7 million in cash, cash equivalents, and marketable securities as of December 31, 2025, and outlined continued investment in research and platform expansion. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDL8HfSmx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2602557734","title":"BRIEF-Stoke Therapeutics Expects To Complete Enrollment Of 150 Patients In Q2 2026, With A Phase 3 Data Readout In Mid-2027 for Zorevunersen","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557734","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602557734?lang=en_us&edition=fundamental","pubTime":"2026-01-12 03:03","pubTimestamp":1768158189,"startTime":"0","endTime":"0","summary":"BRIEF-Stoke Therapeutics Expects To Complete Enrollment Of 150 Patients In Q2 2026, With A Phase 3 Data Readout In Mid-2027 for ZorevunersenJan 11 (Reuters) - Stoke Therapeutics Inc STOK.O:STOKE THERA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nTUA8ZB7PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"gpt_icon":0},{"id":"2602557201","title":"Stoke Therapeutics Accelerates Phase 3 EMPEROR Study Enrollment for Dravet Syndrome Drug Zorevunersen","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557201","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602557201?lang=en_us&edition=fundamental","pubTime":"2026-01-12 03:00","pubTimestamp":1768158021,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Inc. announced updates to the clinical development timeline for its lead investigational medicine, zorevunersen, which is being developed in collaboration with Biogen as a potential disease-modifying treatment for Dravet syndrome. The company now expects to complete enrollment of 150 patients in the Phase 3 EMPEROR study by the second quarter of 2026. A data readout from this study is anticipated in mid-2027 and is expected to support a New Drug Application  submission to the U.S. Food and Drug Administration . Stoke Therapeutics plans to initiate a rolling NDA submission in the first half of 2027. Results from the Phase 3 EMPEROR study have not yet been presented. The company also noted ongoing discussions with the FDA regarding the expedited development and potential registration of zorevunersen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, thi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDLLtp8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","BK4588","BK4139","BK4532","LU0320765992.SGD","IE00B894F039.SGD","BK4585","STOK","BIIB","LU0109394709.USD","BK4533","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2602572025","title":"Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout From the Emperor Study of Zorevunersen for the Treatment of Dravet Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2602572025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602572025?lang=en_us&edition=fundamental","pubTime":"2026-01-12 03:00","pubTimestamp":1768158003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nTUA8ZB7PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STOK","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}]}}